American Board of Obesity, Denver, Colorado; Department of Surgery, Mount Auburn Hospital, Harvard Medical School, Cambridge, Massachusetts.
American Board of Obesity, Denver, Colorado; Department of Surgery, Lewis Katz School of Medicine at Temple University, St. Luke's University and Health Network, Philadelphia, Pennsylvania.
Surg Obes Relat Dis. 2022 Sep;18(9):1109-1119. doi: 10.1016/j.soard.2022.07.002. Epub 2022 Jul 14.
The following literature search is in response to inquiries made to the American Society for Metabolic and Bariatric Surgery (ASMBS) regarding antiobesity medication (AOM) use in patients who are having or have already had metabolic and bariatric surgery (MBS). These recommendations are based on current clinical knowledge, expert opinion, and published peer-reviewed scientific evidence available at this time. This paper is not intended to establish a local, regional, or national standard of care. The paper will be revised in the future as additional evidence becomes available.
以下文献检索是针对美国代谢与减重外科学会（ASMBS）就代谢与减重手术（MBS）患者或已接受代谢与减重手术患者使用抗肥胖药物（AOM）的咨询而进行的。这些建议基于当前的临床知识、专家意见和已发表的同行评议科学证据。本文无意制定当地、区域或国家的护理标准。随着更多证据的出现，本文将在未来进行修订。
